SERCA2 activity is involved in the CNP‐mediated functional responses in failing rat myocardium
- 27 August 2013
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 170 (2) , 366-379
Abstract
Background and Purposes: Myocardial C‐type natriuretic peptide (CNP) levels are increased in heart failure. CNP can induce negative inotropic (NIR) and positive lusitropic responses (LR) in normal hearts, but its effects in failing hearts are not known. We studied the mechanism of CNP‐induced NIR and LR in failing hearts and determined whether sarcoplasmatic reticulum Ca2+ ATPase2 (SERCA2) activity is essential for these responses.Experimental Approach: Contractility, cGMP levels, Ca2+ transient amplitudes and protein phosphorylation were measured in left ventricular muscle strips or ventricular cardiomyocytes from failing hearts of Wistar rats 6 weeks after myocardial infarction.Key Results: CNP increased cGMP levels, evoked a NIR and LR in muscle strips, and caused phospholamban (PLB) Ser16 and troponin I (TnI) Ser23/24 phosphorylation in cardiomyocytes. Both the NIR and LR induced by CNP were reduced in the presence of a PKG blocker/cGMP analogue (Rp‐8‐Br‐Pet‐cGMPS) and the SERCA inhibitor thapsigargin. CNP increased the amplitude of the Ca2+ transient and increased SERCA2 activity in cardiomyocytes. The CNP‐elicited NIR and LR were not affected by the L‐type Ca2+ channel activator BAY‐K8644, but were abolished in the presence of isoprenaline (induces maximal activation of cAMP pathway). This suggests that phosphorylation of PLB and TnI by CNP causes both a NIR and LR. The NIR to CNP in mouse heart was abolished 8 weeks after cardiomyocyte‐specific inactivation of the SERCA2 gene.Conclusions and Implications: We conclude that CNP‐induced PLB and TnI phosphorylation by PKG in concert mediate both a predictable LR as well as the less expected NIR in failing hearts.Keywords
This publication has 36 references indexed in Scilit:
- Guide to Receptors and Channels (GRAC), 5th editionBritish Journal of Pharmacology, 2011
- Cardiac gene therapy with SERCA2a: From bench to bedsideJournal of Molecular and Cellular Cardiology, 2011
- Cre-loxP DNA recombination is possible with only minimal unspecific transcriptional changes and without cardiomyopathy in Tg(αMHC-MerCreMer) miceAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- Guidelines for reporting experiments involving animals: the ARRIVE guidelinesBritish Journal of Pharmacology, 2010
- Animal research: Reporting in vivo experiments: The ARRIVE guidelinesBritish Journal of Pharmacology, 2010
- Sodium accumulation promotes diastolic dysfunction in end-stage heart failure followingSerca2knockoutThe Journal of Physiology, 2010
- SERCA Inhibition Limits the Functional Effects of Cyclic GMP in Both Control and Hypertrophic Cardiac MyocytesPharmacology, 2009
- Cardiac Transgenic and Gene Transfer Strategies Converge to Support an Important Role for Troponin I in Regulating Relaxation in Cardiac MyocytesCirculation Research, 2007
- Effects of Protein Kinase A Phosphorylation on Signaling between Cardiac Troponin I and the N-Terminal Domain of Cardiac Troponin CBiochemistry, 1997
- cGMP‐dependent protein kinase decreases calcium sensitivity of skinned cardiac fibersFEBS Letters, 1982